Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:HTBX

Heat Biologics (HTBX) Stock Price, News & Analysis

Heat Biologics logo

About Heat Biologics Stock (NASDAQ:HTBX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$2.38
$2.38
52-Week Range
N/A
Volume
43,600 shs
Average Volume
171,558 shs
Market Capitalization
$61.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Heat Biologics, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Phase I clinical trial for the treatment of advanced solid tumors. Its products also include PTX-35, a novel T-cell co-stimulator agonist antibody targeting DR3/TNFRSF25 that is in Phase I clinical trial; DR3/TNFRSF25 for various immunotherapy approaches; and COVID-19 vaccine, which is in preclinical stage. Heat Biologics, Inc. has a collaboration with Dr. James Shapiro at University of Alberta to manufacture surrogate mouse version of PTX-35. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina.

Receive HTBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heat Biologics and its competitors with MarketBeat's FREE daily newsletter.

HTBX Stock News Headlines

Is Heat Pump Refrigerant Safe?
Scorpius Holdings Inc (SCPX)
Trump’s treachery
Intuitive Surgical at $1.99. Nvidia at $11. Shorting Fannie Mae months before collapse. That’s this analyst’s record. Now, he’s warning investors again—this time about six stocks he says are uniquely connected to Trump’s early-term policy agenda. With the 100-day mark fast approaching, he believes acting early is critical.
What Wall Street expects from Heat Biologics's earnings
See More Headlines

HTBX Stock Analysis - Frequently Asked Questions

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:HTBX
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$61.05 million
Optionable
Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:HTBX) was last updated on 4/22/2025 by MarketBeat.com Staff
From Our Partners